IEX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/18/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeIEX
Market Capitalization7,498.74 mln
Float154 mln
Earnings Date07/29/2026
EPS
0.90
Stretched
P / E
49.89
High premium
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-1.4
Manipulation likely
1-Year Forecast
46.12
Fairly priced
Relative Strength
79
/ 100
Strongly outperforming
Business Description
Alkermes is an Ireland-based biopharmaceutical company founded in 1987 that develops and sells treatments for serious conditions including schizophrenia, bipolar disorder, alcohol dependence, and opioid dependence, with products sold primarily in the United States. Its lineup includes several established medications delivered in various forms, from monthly injections to oral tablets, as well as a sleep disorder treatment for children. The company also licenses its drug delivery technology to other pharmaceutical firms and maintains a long-standing partnership with Janssen Pharmaceutica to develop and commercialize additional products.